Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis
1 Oncology Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. b.maiorano@operapadrepio.it.
2 Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
3 Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
4 Oncology Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
5 Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy.
6 Division of Medical Oncology, Department of Oncology, University of Turin, Turin, Italy.